Jermendy, György <br/><br/>
[Effectiveness of one-year insulin glargine and insulin glulisine basal-bolus treatment in people with type 2 diabetes. An analysis from drug reimbursement perspective].  [electronic resource] 

 -  Orvosi hetilap  Dec 2018 
 - 2122-2128 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0030-6002 
<br/><br/><label>Standard No.: </label>10.1556/650.2018.31214  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Female<br/>Humans<br/>Hungary<br/>Hypoglycemic Agents--administration & dosage<br/>Insulin Glargine--administration & dosage<br/>Insulin, Long-Acting--administration & dosage<br/>Male<br/>Middle Aged<br/>Reimbursement Mechanisms--statistics & numerical data<br/>Treatment Outcome